Skip to main content

Peer Review reports

From: Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie)

Original Submission
15 Apr 2017 Submitted Original manuscript
18 Jun 2017 Reviewed Reviewer Report - david tougeron
21 Aug 2017 Reviewed Reviewer Report - Hans Prenen
29 Aug 2017 Reviewed Reviewer Report - Luciano Cascione
29 Sep 2017 Author responded Author comments - Florian Huemer
Resubmission - Version 2
29 Sep 2017 Submitted Manuscript version 2
2 Oct 2017 Reviewed Reviewer Report - Hans Prenen
1 Dec 2017 Author responded Author comments - Florian Huemer
Resubmission - Version 3
1 Dec 2017 Submitted Manuscript version 3
15 Dec 2017 Reviewed Reviewer Report - Hans Prenen
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
21 Dec 2017 Editorially accepted
3 Jan 2018 Article published 10.1186/s12885-017-3955-4

You can find further information about peer review here.

Back to article page